Key Insights

Highlights

Treatment Research

6 treatments under study, led by Continuous Popliteal Nerve Block With Normal Saline

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Enrolling By Invitation1

Clinical Trials (1)

Research Network

Common Treatments

  • Continuous Popliteal Nerve Block With Normal Saline1
  • Adductor Canal Nerve Block Including Liposomal Bupivacaine1
  • Continuous Popliteal Nerve Block With Unencapsulated Bupivacaine1
  • Adductor Canal Nerve Block With Exclusively Unencapsulated Bupivacaine1
  • Popliteal Nerve Block Including Liposomal Bupivacaine1

Active Sponsors

  • Pacira Biosciences1
  • University of California, San Diego1

Top Investigators

Activity Timeline